Extreme Thrombocytosis not always Essential ThrombocythemiaBCR-ABL has to be Done Timely
Author(s) -
Uzma Mahar,
Nida Anwar,
Jawad Hassan,
Tahir Shamsi
Publication year - 2019
Publication title -
national journal of health sciences
Language(s) - English
Resource type - Journals
eISSN - 2519-7878
pISSN - 2519-7053
DOI - 10.21089/njhs.43.0126
Subject(s) - thrombocytosis , medicine , hydroxycarbamide , myeloid leukemia , anagrelide , philadelphia chromosome , essential thrombocythemia , platelet , myeloproliferative neoplasm , gastroenterology , bone marrow examination , myeloid , nilotinib , leukemia , bone marrow , immunology , imatinib , myelofibrosis , biology , chromosomal translocation , chemotherapy , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom